Alterity receives MHRA authorisation for Phase II trial of MSA therapy
Alterity Therapeutics has received the MHRA acceptance for its request to proceed with Phase II trial of ATH434 in MSA.
Source: clinicaltrialsarena.com
Page 4 - Sample Services News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sample Services. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sample Services Today - Breaking & Trending Today
Priothera to start Phase IIb/III trial of acute myeloid leukaemia therapy
Priothera has announced plans to commence Phase IIb/III trial of mocravimod in acute myeloid leukaemia patients undergoing allogeneic HSCT.
Source: clinicaltrialsarena.com
Shionogi's Covid-19 antiviral offers quick virus clearance in Asian trials
Shionogi has reported data from two trials of Covid-19 antiviral, S-217622, that concluded in Asia demonstrated rapid clearance of the virus.
Source: clinicaltrialsarena.com
Alopecia areata in the spotlight in time for possible treatment paradigm shift
Clinical Trials Arena looks at a potential shake-up in alopecia areata's treatment paradigm and an emerging treatment mechanism.
Source: clinicaltrialsarena.com
FDA grants clearance for Sorrento Phase II/III Covid-19 therapy trial
Sorrento Therapeutics has obtained the US FDA clearance to initiate the Phase II/III trial of Abivertinib in hospitalised Covid-19 patients.
Source: clinicaltrialsarena.com